EVA DZIERGOWSKA: Open Payments
NPI 1194337253 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 17 payments from 8 companies in 2025. Trend: 2023 $893 · 2024 $410 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 8 | $261 |
| Janssen Biotech, Inc. | 2 | $209 |
| E.R. Squibb & Sons, L.L.C. | 1 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Alkermes, Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: INGREZZA, TREMFYA, COBENFY, UZEDY, Auvelity, ARISTADA, REXULTI, CAPLYTA.
Industry payments across NY — which companies pay providers there.
